You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

FLOXURIDINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Floxuridine patents expire, and what generic alternatives are available?

Floxuridine is a drug marketed by Am Regent, Fresenius Kabi Usa, and Hikma. and is included in three NDAs.

The generic ingredient in FLOXURIDINE is floxuridine. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the floxuridine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Floxuridine

A generic version of FLOXURIDINE was approved as floxuridine by HIKMA on April 16th, 2000.

  Try a Trial

Drug patent expirations by year for FLOXURIDINE
Drug Prices for FLOXURIDINE

See drug prices for FLOXURIDINE

Recent Clinical Trials for FLOXURIDINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
ECOG-ACRIN Cancer Research GroupPhase 3
Oslo University HospitalPhase 2
Luye Pharma Group Ltd.Phase 1/Phase 2

See all FLOXURIDINE clinical trials

Pharmacology for FLOXURIDINE
Drug ClassAntimetabolite
Medical Subject Heading (MeSH) Categories for FLOXURIDINE

US Patents and Regulatory Information for FLOXURIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent FLOXURIDINE floxuridine INJECTABLE;INJECTION 203008-001 Nov 22, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Fresenius Kabi Usa FLOXURIDINE floxuridine INJECTABLE;INJECTION 075837-001 Feb 22, 2001 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma FLOXURIDINE floxuridine INJECTABLE;INJECTION 075387-001 Apr 16, 2000 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.